165 related articles for article (PubMed ID: 38855648)
1. Attitudes of European psychiatrists on psychedelics: a qualitative study.
Žuljević MF; Breški N; Kaliterna M; Hren D
Front Psychiatry; 2024; 15():1411234. PubMed ID: 38855648
[TBL] [Abstract][Full Text] [Related]
2. [Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland].
Olafsson RP; Kvaran K; Ketilsdottir K; Hallgrimsdottir K; Sigurdsson EL; Sigurdsson E
Laeknabladid; 2023 Nov; 109(11):495-503. PubMed ID: 37909445
[TBL] [Abstract][Full Text] [Related]
3. The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy.
Page LA; Rehman A; Syed H; Forcer K; Campbell G
Front Psychiatry; 2021; 12():743599. PubMed ID: 35756728
[No Abstract] [Full Text] [Related]
4. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
Barber GS; Dike CC
Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705
[TBL] [Abstract][Full Text] [Related]
5. Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.
Nadeem Z; Parker S; McGovern H; Oestreich LK
Aust N Z J Psychiatry; 2024 Jun; ():48674241261779. PubMed ID: 38907608
[TBL] [Abstract][Full Text] [Related]
6. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
Barnett BS; Greer GR
J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
[TBL] [Abstract][Full Text] [Related]
7. UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.
Song-Smith C; Jacobs E; Rucker J; Saint M; Cooke J; Schlosser M
BMJ Open; 2024 Mar; 14(3):e083595. PubMed ID: 38485474
[TBL] [Abstract][Full Text] [Related]
8. The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists.
Berger JJ; Fitzgerald PB
Australas Psychiatry; 2023 Apr; 31(2):190-194. PubMed ID: 36779819
[TBL] [Abstract][Full Text] [Related]
9. Medical student attitudes and perceptions of psychedelic-assisted therapies.
Li I; Fong R; Hagen M; Tabaac B
Front Psychiatry; 2023; 14():1190507. PubMed ID: 37441143
[TBL] [Abstract][Full Text] [Related]
10. A survey of Australian psychiatrists' and psychiatry trainees' knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders.
Grover C; Monds L; Montebello M
Australas Psychiatry; 2023 Jun; 31(3):329-335. PubMed ID: 36753675
[TBL] [Abstract][Full Text] [Related]
11. Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics.
Kucsera A; Suppes T; Haug NA
Clin Psychol Psychother; 2023; 30(6):1369-1379. PubMed ID: 37394242
[TBL] [Abstract][Full Text] [Related]
12. Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice.
Gorman I; Nielson EM; Molinar A; Cassidy K; Sabbagh J
Front Psychol; 2021; 12():645246. PubMed ID: 33796055
[TBL] [Abstract][Full Text] [Related]
13. Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.
Corrigan K; Haran M; McCandliss C; McManus R; Cleary S; Trant R; Kelly Y; Ledden K; Rush G; O'Keane V; Kelly JR
Ir J Med Sci; 2022 Jun; 191(3):1385-1397. PubMed ID: 34131812
[TBL] [Abstract][Full Text] [Related]
14. Addiction specialists' attitudes toward psychedelics: A National Survey.
Kim A; Suzuki J
Am J Addict; 2023 Nov; 32(6):606-609. PubMed ID: 37550848
[TBL] [Abstract][Full Text] [Related]
15. Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.
Greenway KT; Garel N; Jerome L; Feduccia AA
Expert Rev Clin Pharmacol; 2020 Jun; 13(6):655-670. PubMed ID: 32478631
[TBL] [Abstract][Full Text] [Related]
16. Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.
Holoyda B
Psychiatr Serv; 2020 Dec; 71(12):1297-1299. PubMed ID: 33050796
[TBL] [Abstract][Full Text] [Related]
17. Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.
Perkins D; Sarris J; Rossell S; Bonomo Y; Forbes D; Davey C; Hoyer D; Loo C; Murray G; Hood S; Schubert V; Galvão-Coelho NL; O'Donnell M; Carter O; Liknaitzky P; Williams M; Siskind D; Penington D; Berk M; Castle D
Aust N Z J Psychiatry; 2021 Dec; 55(12):1127-1133. PubMed ID: 33745287
[TBL] [Abstract][Full Text] [Related]
18. Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.
Davis AK; Agin-Liebes G; España M; Pilecki B; Luoma J
J Psychoactive Drugs; 2022; 54(4):309-318. PubMed ID: 34468293
[TBL] [Abstract][Full Text] [Related]
19. Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey.
Barnett BS; Beaussant Y; King F; Doblin R
J Psychoactive Drugs; 2022; 54(3):269-277. PubMed ID: 34409921
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
